PHOENIX - Arizonar -- Since introducing Nanosecond Pulsed Field Ablation (nsPFA™) treatment in 2025, Richard J. Harding, MD, FACS, has continued to expand access to this non surgical option for patients with symptomatic benign thyroid nodules. As one of the earliest U.S. physicians to adopt nsPFA™, Dr. Harding is now seeing increased interest from primary care providers, endocrinologists, and ENT specialists seeking alternatives to conventional thyroid surgery.

Pulse Biosciences, the developer of nsPFA™ technology, recognizes Dr. Harding's leadership in bringing this innovative, non thermal ablation method to patients in the Phoenix region.

"nsPFA represents a meaningful advancement in thyroid nodule care," said Doug Polzin of Pulse Biosciences. "Traditional thermal ablation methods such as RFA and microwave ablation rely on heat, which can pose risks to surrounding structures. nsPFA uses ultrashort electrical pulses to precisely target nodule tissue while preserving nearby nerves and critical anatomy. We're excited to see physicians like Dr. Harding bringing this technology to patients who want a safe, effective, non surgical option.

More on The Arizonar

• Captain Notepad Expands Free Custom Design Services Across Full Product Line
• Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
• YOKE Expands NIL Club Into Athlete-Led Commerce With Athlete Merch Launch
• Floor Kings Announces Official Launch of Premier Epoxy Flooring Services Across Arizona
• UK Buyers Purchase Luxury Home in Keene's Pointe, Windermere (Orlando, Florida)

Benign thyroid nodules are common and can cause pressure, discomfort, difficulty swallowing, or cosmetic concerns. Historically, patients seeking relief often faced limited choices: monitoring, medication, or surgery. nsPFA™ offers a new pathway—one that precisely targets nodule tissue while preserving surrounding structures and avoiding the risks associated with heat‑based ablation.

https://youtu.be/1eG6x0W9CW0?si=VROgIiIq4JDzKSns



"In my practice, nsPFA™ has shown excellent outcomes with minimal downtime," said Dr. Harding. "Patients appreciate having a non‑surgical option that preserves thyroid function and allows them to return to normal activities quickly."

About the Thyroid Nodule Treatment Center:
The Thyroid Nodule Treatment Center, specializes in the diagnosis and treatment of thyroid nodules. The mission of the Thyroid Nodule Treatment Center (TNTC) is the preservation of normal thyroid function while treating benign symptomatic thyroid nodules using the most advanced minimally invasive treatments available. Under the expert leadership of Dr. Richard Harding, the center is committed to providing patients with the latest and most effective treatment options in a compassionate and supportive environment.

More on The Arizonar

• Instant IP Launches Rapid Takedown Service to Combat IP Theft, Deepfakes, and Copycat Websites
• Su Che Publishing Announces New Children's Book Celebrating Vaisakhi Festival
• City of Mesa Seeking Applicants for Advisory Boards and Committees
• Permian Museum Adds Photos of Fossils Discovered on a Meteorite
• This Saturday: Open House for Manalapan's Newest Single Family Home Community

2320 N. Third Street
Phoenix, AZ 85004
https://thyroidnoduletreatment.center

About Pulse Biosciences, Inc.
Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
3957 Point Eden Way, Hayward, CA 94545
http://www.pulsebiosciences.com